WallStSmart

Braskem SA Class A (BAK)vsREX American Resources Corporation (REX)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Braskem SA Class A generates 10621% more annual revenue ($70.60B vs $658.58M). REX leads profitability with a 18.3% profit margin vs -7.8%. BAK appears more attractively valued with a PEG of 1.46. REX earns a higher WallStSmart Score of 70/100 (B-).

BAK

Hold

48

out of 100

Grade: D+

Growth: 6.7Profit: 4.0Value: 5.3Quality: 4.5
Piotroski: 3/9Altman Z: 0.13

REX

Strong Buy

70

out of 100

Grade: B-

Growth: 6.0Profit: 7.5Value: 7.3Quality: 9.0
Piotroski: 4/9Altman Z: 7.21
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BAK.

REXUndervalued (+23.2%)

Margin of Safety

+23.2%

Fair Value

$46.44

Current Price

$40.23

$6.21 discount

UndervaluedFair: $46.44Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BAK3 strengths · Avg: 9.3/10
EPS GrowthGrowth
107.2%10/10

Earnings expanding 107.2% YoY

Debt/EquityHealth
-5.4310/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
21.6%8/10

Revenue surging 21.6% year-over-year

REX5 strengths · Avg: 9.6/10
P/E RatioValuation
10.9x10/10

Attractively priced relative to earnings

EPS GrowthGrowth
390.2%10/10

Earnings expanding 390.2% YoY

Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
7.2110/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Areas to Watch

BAK4 concerns · Avg: 2.5/10
Market CapQuality
$438.33M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-549.0%2/10

ROE of -549.0% — below average capital efficiency

Free Cash FlowQuality
$-535.00M2/10

Negative free cash flow — burning cash

REX2 concerns · Avg: 3.5/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Market CapQuality
$1.32B3/10

Smaller company, higher risk/reward

Comparative Analysis Report

WallStSmart Research

Bull Case : BAK

The strongest argument for BAK centers on EPS Growth, Debt/Equity, Revenue Growth. Revenue growth of 21.6% demonstrates continued momentum. PEG of 1.46 suggests the stock is reasonably priced for its growth.

Bull Case : REX

The strongest argument for REX centers on P/E Ratio, EPS Growth, Debt/Equity. Profitability is solid with margins at 18.3% and operating margin at 15.4%.

Bear Case : BAK

The primary concerns for BAK are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : REX

The primary concerns for REX are PEG Ratio, Market Cap.

Key Dynamics to Monitor

BAK profiles as a growth stock while REX is a mature play — different risk/reward profiles.

BAK carries more volatility with a beta of 0.77 — expect wider price swings.

BAK is growing revenue faster at 21.6% — sustainability is the question.

REX generates stronger free cash flow (17M), providing more financial flexibility.

Bottom Line

REX scores higher overall (70/100 vs 48/100), backed by strong 18.3% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Braskem SA Class A

BASIC MATERIALS · CHEMICALS · USA

Braskem SA produces and markets thermoplastic resins. The company is headquartered in Camaari, Brazil.

REX American Resources Corporation

BASIC MATERIALS · CHEMICALS · USA

REX American Resources Corporation, produces and sells ethanol in the United States. The company is headquartered in Dayton, Ohio.

Visit Website →

Want to dig deeper into these stocks?